{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:57:35Z","timestamp":1773813455990,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T00:00:00Z","timestamp":1555718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13256-019-2018-7","type":"journal-article","created":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T00:02:31Z","timestamp":1555718551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report"],"prefix":"10.1186","volume":"13","author":[{"given":"Tomohisa","family":"Kunii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4613-3744","authenticated-orcid":false,"given":"Toshie","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruo","family":"Jojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Kogai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Aso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,20]]},"reference":[{"issue":"5","key":"2018_CR1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1053\/j.ajkd.2005.02.010","volume":"45","author":"H Izzedine","year":"2005","unstructured":"Izzedine H, Launay-Vacher V, Deray G. Antiviral drug-induced nephrotoxicity. Am J Kidney Dis. 2005;45(5):804\u201317.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2018_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1210\/jc.2009-2051","volume":"95","author":"T Wong","year":"2010","unstructured":"Wong T, Girgis CM, Ngu MC, Chen RC, Emmett L, et al. Hypophosphatemic osteomalacia after low-dose adefovir dipivoxil therapy for hepatitis B. J Clin Endocrinol Metab. 2010;95(2):479\u201380.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2018_CR3","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/MCG.0b013e3181e12ed3","volume":"45","author":"CM Girgis","year":"2011","unstructured":"Girgis CM, Wong T, Ngu MC, Emmett L, Archer KA, et al. Hypophosphataemic osteomalacia in patients on adefovir dipivoxil. J Clin Gastroenterol. 2011;45(5):468\u201373.","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"2018_CR4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1517\/17425255.2015.1000860","volume":"11","author":"S Zaheer","year":"2015","unstructured":"Zaheer S, LeBoff M, Lewiecki EM. Denosumab for the treatment of osteoporosis. Expert Opin Drug Metab Toxicol. 2015;11(3):461\u201370.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2018_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/qjmed\/hct258","volume":"107","author":"AM Hall","year":"2014","unstructured":"Hall AM, Bass P, Unwin RJ. Drug-induced renal Fanconi syndrome. QJM. 2014;107:261\u20139.","journal-title":"QJM"},{"issue":"7","key":"2018_CR6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1053\/hupa.2001.25586","volume":"32","author":"N Tanji","year":"2001","unstructured":"Tanji N, Tanji K, Kambham N, Markowitz GS, Bell A, et al. Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. Hum Pathol. 2001;32(7):734\u201340.","journal-title":"Hum Pathol"},{"issue":"3","key":"2018_CR7","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/j.1523-1755.2004.00866.x","volume":"66","author":"H Izzedine","year":"2004","unstructured":"Izzedine H, Hulot JS, Launay-Vacher V, Marcellini P, Hadziyannis SJ, et al. Adefovir Dipivoxil International 438 Study Group. Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies. Kidney Int. 2004;66(3):1153\u20138.","journal-title":"Kidney Int"},{"issue":"3","key":"2018_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2169\/internalmedicine.53.1213","volume":"53","author":"H Eguchi","year":"2014","unstructured":"Eguchi H, Tsuruta M, Tani J, Kuwahara R, Hiromatsu Y. Hypophosphatemic osteomalacia due to drug-induced Fanconi\u2019s syndrome associated with adefovir dipivoxil treatment for hepatitis B. Intern Med. 2014;53(3):233\u20137.","journal-title":"Intern Med"},{"issue":"3","key":"2018_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/jcpt.12259","volume":"40","author":"BF Wang","year":"2015","unstructured":"Wang BF, Wang Y, Wang BY, Sun FR, Zhang D, et al. Osteomalacia and Fanconi\u2019s syndrome caused by long-term low-dose adefovir dipivoxil. J Clin Pharm Ther. 2015;40(3):345\u20138.","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"2018_CR10","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00774-004-0594-z","volume":"23","author":"I Ros","year":"2005","unstructured":"Ros I, Alvarez L, Gua\u00f1abens N, Peris P, Monegal A, et al. Hypophosphatemic osteomalacia: a report of five cases and evaluation of bone markers. J Bone Miner Metab. 2005;23(3):266\u20139.","journal-title":"J Bone Miner Metab"},{"key":"2018_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/978-3-319-29182-6_81","volume-title":"Bone disorders: biology, diagnosis, prevention, therapy","author":"R Bartl","year":"2017","unstructured":"Bartl R, Bartl C. Drug-induced osteoporomalacia. In: Bone disorders: biology, diagnosis, prevention, therapy. Cham: Springer; 2017. p. 441\u20132."},{"issue":"8","key":"2018_CR12","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, et al. FREEDOM Trial. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361(8):756\u201365. A published erratum appears in N Engl J Med. 2009;361(19):1914","journal-title":"N Engl J Med"},{"issue":"16","key":"2018_CR13","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1016\/j.ejca.2012.08.002","volume":"48","author":"A Lipton","year":"2012","unstructured":"Lipton A, Fizazi K, Stopeck AT, Henry DH, Brown JE, et al. Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials. Eur J Cancer. 2012;48(16):3082\u201392.","journal-title":"Eur J Cancer"},{"key":"2018_CR14","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00198-013-2533-0","volume":"25","author":"H Shafqat","year":"2014","unstructured":"Shafqat H, Alquadan KF, Olszewski AJ. Severe hypocalcemia after densumab in a patient with acquired Fanconi syndrome. Osteoporos Int. 2014;25:1187\u201390.","journal-title":"Osteoporos Int"},{"issue":"2","key":"2018_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00198-018-4679-2","volume":"30","author":"T.-L. Chung","year":"2018","unstructured":"Chung TL, Chen NC, Chen CL. Severe hypophosphatemia induced by denosumab in a patient with osteomalacia and tenofovir disoproxil fumarate-related acquired Fanconi syndrome. Osteoporos Int. \n                    https:\/\/doi.org\/10.1007\/s00198-018-4679-2\n                    \n                  .","journal-title":"Osteoporosis International"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2018-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-019-2018-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2018-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T23:03:41Z","timestamp":1587251021000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-019-2018-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,20]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2018"],"URL":"https:\/\/doi.org\/10.1186\/s13256-019-2018-7","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,20]]},"assertion":[{"value":"22 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"It was not required to submit the case to the institutional ethics committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"99"}}